Literature DB >> 3964537

The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.

J V Watson, J Stewart, G I Evan, A Ritson, K Sikora.   

Abstract

A sensitive flow cytometric assay has been developed using a monoclonal antibody, Myc 1-6E10, to quantitate c-myc oncoprotein levels in nuclei isolated from wax embedded testicular tumours. The oncoprotein (p62c-myc) level increased significantly with increasing teratoma differentiation. Patients with intermediate and undifferentiated tumours who developed recurrence had lower p62c-myc levels than those who were disease free since their initial treatment. Such quantitative biochemical methods may provide new prognostic indices for cancer patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964537      PMCID: PMC2001357          DOI: 10.1038/bjc.1986.56

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Oncogenes.

Authors:  P Hamlyn; K Sikora
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

Review 2.  Cancer genes come of age.

Authors:  J M Bishop
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

3.  Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.

Authors:  R Dalla-Favera; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

6.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines.

Authors:  C D Little; M M Nau; D N Carney; A F Gazdar; J D Minna
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

7.  Dual laser beam focussing for flow cytometry through a single crossed cylindrical lens pair.

Authors:  J V Watson
Journal:  Cytometry       Date:  1981-07

8.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

Review 9.  The emerging genetics of human cancer.

Authors:  T G Krontiris
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

10.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  14 in total

Review 1.  Demystified ... oncogenes.

Authors:  Y L Wallis; F Macdonald
Journal:  Mol Pathol       Date:  1999-04

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  c-myc oncoprotein levels in bladder cancer.

Authors:  J R Masters; S G Vesey; C F Munn; G I Evan; J V Watson
Journal:  Urol Res       Date:  1988

Review 4.  Oncogenes and urological malignancies: implications for the future.

Authors:  J A Schalken; A M van den Ouweland; F M Debruijne; H F Karthaus; W J Van de Ven
Journal:  Urol Res       Date:  1988

5.  c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.

Authors:  J S Chana; G D Wilson; I A Cree; R A Alexander; N Myatt; M Neale; A J Foss; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

6.  The expression of c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung.

Authors:  Jinyoung Yoo; Ji Han Jung; Hyun Joo Choi; Seok Jin Kang; Chang Suk Kang
Journal:  Cancer Res Treat       Date:  2004-04-30       Impact factor: 4.679

Review 7.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

8.  C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.

Authors:  S V Polacarz; N A Hey; T J Stephenson; A S Hill
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

Review 9.  Changes in c-onc expression during embryonal carcinoma cell differentiation.

Authors:  T Sejersen; P Jin; M Rahm; N R Ringertz
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

Review 10.  Germ cell tumour chemotherapy.

Authors:  A Horwich
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.